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Abstract We recently demonstrated that the sphingomyelin
(SM) content of adipocyte membranes was negatively correlated
with the expression of peroxisome proliferator-activated recep-
tor-Q (PPARQ) in the subcutaneous adipose tissue of obese
women with variable degrees of insulin resistance. We have now
investigated whether SM really does have an impact on the
expression of PPARQ in 3T3-F442A adipocytes. Adding SM to
the culture medium for 24 h caused a significant increase in SM
content of adipocyte membranes and an acyl chain length-
dependent decrease in the levels of PPARQ mRNA and protein.
The longer the acyl chain of the fatty acid of SM, the greater was
the decrease in PPARQ. These data suggest that the nature of the
fatty acid is important in the regulation of PPARQ by the SM
pathway. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Sphingomyelin (SM) is a phosphosphingolipid that has long
been known to play a part in the structure and dynamic prop-
erties of cell membranes [1]. Recent studies have revealed the
critical role of SM in signal transduction [2,3]. SM and its
metabolites, ceramide and sphingosine, are important intra-
cellular messengers and cell regulatory molecules that mediate
at least part of the action of extracellular agents such as tu-
mor necrosis factor-K (TNF-K), Q-interferon, interleukin-1L
and 1K,25-dihydroxyvitamin D3 [4,5].
There is also evidence that the SM pathway plays a role in
insulin signal transduction by modulating gene expression in
insulin-sensitive cells. TNF-K inhibits insulin signaling by
stimulating sphingomyelinase activity and generating ceram-
ide [6,7]. Ceramide mediates the down-regulation of glucose
transporter (Glut4) mRNA [8]. TNF-K also down-regulates
the production of the peroxisome proliferator-activated recep-
tor-Q (PPARQ) [9], a transcription factor that is abundant in
adipose tissue and may also play a role in the sensitivity of
cells to insulin [10]. Our study on obese women with varying
degrees of insulin resistance showed that the concentrations of
PPARQ mRNA are negatively correlated with fasting plasma
insulin, a marker of insulin resistance, and with the membrane
SM contents of the subcutaneous adipose tissue [11]. The
most insulin-resistant women had higher SM contents in their
adipocyte plasma membranes, and also lower concentrations
of PPARQ mRNA.
This link between PPARQ expression and SM led us to
investigate the regulation of PPARQ by SM. This study was
done to determine whether the in vitro uptake of exogenous
SMs into cultured adipocytes could regulate PPARQ expres-
sion. We show that PPARQ gene expression and protein con-
centration undergo SM-dependent down-regulation in 3T3-
F442A adipocytes.
2. Materials and methods
2.1. Materials
Dulbecco’s modi¢ed Eagle’s medium (DMEM), SMs (palmitic,
stearic and nervonic, and lignoceric) and insulin were purchased
from Sigma (Saint Quentin Fallavier, France). Fetal bovine serum
was obtained from Eurobio (Les Ulis, France) and donor bovine
serum from Life Technologies (Cergy Pontoise, France). The primers
for PPARQ and L-actin were obtained from Pharmacia Biotech (Or-
say, France). The anti-PPARQ1/Q2 polyclonal antibody raised against
both PPARQ1 and PPARQ2 was from Interchim (Montluc°on, France).
The speci¢c polyclonal antibody directed against PPARQ2 has been
previously described [12]. The sheep anti-rabbit immunoglobulin G
polyclonal antibody conjugated with peroxidase and the chemilumi-
nescent substrate used in ECL-Western analysis were provided by
Boehringer Mannheim Biochemica (Mannheim, Germany). Molecular
mass markers for proteins were obtained from Pharmacia (Orsay,
France). Polyvinylidene di£uoride membranes for Western blotting
were purchased from NEN (Paris, France). The protein assay kit
was from Bio-Rad (Ivry-sur-Seine, France).
2.2. Cell culture
3T3-F442A cells [13] were cultured in DMEM containing 25 mM
glucose and gentamicin (0.1 g/l), supplemented with 10% (v/v) donor
bovine serum, and were grown to con£uence at 37‡C in an atmos-
phere of air/CO2 (93:7, v/v) in 75 cm2 cell culture £asks. The medium
was changed every 2 days. Two days after con£uence, cells were fed
with di¡erentiation medium (DMEM containing 50 nM insulin and
supplemented with 10% fetal bovine serum). The medium was
changed every 2 days. Before experiments, culture medium was re-
moved and replaced by DMEM without insulin for 2 days. Cells were
used 9^10 days after the induction of di¡erentiation when more than
90% of the cells had an adipocyte-like phenotype.
2.3. Addition of SMs
SM-PA (from chicken eggs) with mainly palmitic acid, SM-SNA
(from bovine brain) with mainly stearic and nervonic acids and SM-
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LA (from bovine erythrocytes) containing mainly lignoceric acid were
used. SMs in absolute ethanol at 37‡C were added to DMEM (SM
¢nal concentration: 15 WM; ethanol to medium ratio: 1/200 (v/v)) and
kept at 37‡C for 10 min. Standard medium was then removed from
the culture £asks and replaced by medium with SM. Control cells
received equivalent amounts of ethanol.
2.4. Semi-quantitative RT-PCR
The culture medium was removed 2 or 24 h after SM or ethanol
treatment, and the cells were washed with cold phosphate-bu¡ered
saline (PBS) (136 mM NaCl, 10 mM Na2HPO4, 2 mM KCl, 1.46
mM KH2PO4 and 5.5 mM D-glucose, pH 7.4).
Total cellular RNA was prepared with the Trizol reagent (Gibco,
Cergy Pontoise, France) following the manufacturer’s instructions.
After electrophoretic veri¢cation of their integrity, mRNAs were re-
verse-transcribed (0.5 Wg) with the First-Strand cDNA Synthesis Kit
(Amersham Pharmacia Biotech, Orsay, France) in 15 Wl ¢nal volume.
2 Wl of the amplicons so obtained was used for duplex PCR coampli-
fying L-actin and PPARQ. Compatible primer sequences were chosen
from the GenBank Database Document Reader. The sense and anti-
sense primers were respectively: 5P-AAA CAT ATC ACC CCC CTG
CA-3P and 5P-GCA GCA GGT TGT CTT GGA TG-3P for PPARQ ;
5P-CCG TGA AAA GAT GAC CCA GA-3P and 5P-GCA CGA TTT
CCC TCT CAG CT-3P for L-actin to amplify the following genomic
region from bp 267 to bp 550 (L-actin) and from bp 1277 to bp 1727
(PPARQ). The sense primers were 5P end-labeled with Cy-5. Duplex
PCRs were carried out in 20 Wl ¢nal volume including 0.25 Wl of Taq
polymerase (1.25 U), 2 Wl of PCR mix, 0.5 Wl of a mixture of the four
deoxynucleotide triphosphates (200 WM each), 2 Wl of each primer pair
(20 pM each) and 2 Wl of the RT reaction (50^70 ng). The cDNA
ampli¢cation program included 28 cycles of denaturation at 92‡C for
1 min, primer annealing at 70‡C for 1 min and extension at 72‡C for
1 min, followed by a ¢nal 10 min extension step at 72‡C. 10 Wl of each
RT-PCR reaction was analyzed by non-denaturing gel electrophoresis
on an ALFexpress sequencing machine (Pharmacia Biotech, Orsay,
France) ¢tted with short plates. The results were analyzed on-line with
the Allele Links software, which allows quanti¢cation of amplicons.
2.5. Western blot analysis
The treated and control cells were harvested and disrupted in cold
10 mM Tris^HCl, pH 7.4, containing 1% (w/v) Triton X-100 at 4‡C
and centrifuged (17 000Ug) for 20 min. The resulting supernatants
were used for protein determination and Western blot analysis. Pro-
tein content was measured by the method of Lowry et al. [14], using
bovine serum albumin as a standard. The total PPARQ (PPARQ1 plus
PPARQ2) and PPARQ2 proteins were quanti¢ed using the ECL-West-
ern blot procedure. Proteins (25 Wg) were resolved by SDS^PAGE,
then transferred to a polyvinylidene di£uoride membrane [15].
PPARQ1/Q2 and PPARQ2 were detected with polyclonal antibodies di-
luted 1/1000 and visualized using an anti-immunoglobulin G polyclon-
al antibody conjugated to peroxidase exposed to a chemiluminescent
substrate. The commercial anti-PPARQ1/Q2 was directed against the
amino acid sequence MMGEDKIKFKHITPL common to both
PPARQ1 and PPARQ2 (amino acids 256^270 of human PPARQ1,
284^298 of human PPARQ2). We used the fact that PPARQ2 di¡ers
from PPARQ1 in having an additional speci¢c N-terminal amino acid
region, to map the sequence of the hapten used to produce the anti-
human PPARQ2 described in [11] in that region. It was
2GETLGDSPIDPESDS16 of human PPARQ2 [16,17]. The polyclonal
antibodies cross-reacted with the corresponding rat PPARQ proteins.
The intensities of the bands were quanti¢ed by densitometry with a
computerized image processing system (Gel Doc 2000, Bio-Rad).
2.6. Membrane cholesterol and phospholipid composition
The culture medium of 3T3-F442A adipocytes in 100 mm dishes
was supplemented or not with SMs (15 WM). After 24 h, the medium
was removed and cells washed twice with cold PBS. Cells were then
processed for the isolation of total membranes. The cells were pipetted
o¡ the dish 5 min after incubation with 3 ml of homogenization bu¡er
(250 mM sucrose, 1 mM EDTA, 10 mM Tris^HCl, pH 7.4), centri-
fuged at 200Ug for 10 min and resuspended in 6 ml of ice-cold
homogenization bu¡er. The cell suspension was homogenized with
15 strokes in a Potter^Kontes homogenizer with a Te£on pestle.
Cell disruption was monitored under the light microscope. Total
membranes were pelleted at 250 000Ug for 90 min [18]. The pellet
was washed twice with 1 mM EDTA, 10 mM Tris^HCl, pH 7.4,
and ¢nally resuspended in 1 ml of 1 mM EDTA, 1 mM Tris^HCl,
10 mM NaCl, pH 7.4. A 50 Wl aliquot was used for the determination
of protein content according to the method of Lowry et al. [14]. Total
membranes were kept at 380‡C.
2.7. Membrane lipid determination
Lipids were extracted from cell total membranes with methanol and
chloroform (11:7, v/v) according to the method of Rose and Oklander
[19]. The amount of membranes used for optimal extraction was 500
Wg protein. The organic phase was evaporated to dryness under a
stream of nitrogen at room temperature. The lipid residue was redis-
solved in chloroform, and its components were separated by HPLC
(Gold HPLC System, Beckman, Palo Alto, CA, USA) [20]. 20 Wg of
lysophosphatidylcholine (lyso-PC) per 100 Wg proteins was added as
internal standard before the extraction. Phospholipids were detected
with an evaporative light scattering detector (SEDERE, Orle¤ans,
France). Quanti¢cation was based on the comparison of integrated
peak area with curves prepared from standard phospholipid solutions.
Membrane cholesterol was quanti¢ed by the method of Zlatkis and
Zak [21].
2.8. Statistical analysis
The results are presented as means þ S.E.M. and have been ana-
lyzed for statistical signi¢cance using Student’s t-test (Statgraphics
software, Manugistics, Rockville, MD, USA). The level of signi¢cance
was set at P6 0.05.
3. Results
3.1. E¡ect of SMs on PPARQ mRNA levels
We determined whether SMs had an e¡ect on PPARQ pro-
duction in the adipocytes by supplementing the culture me-
dium of 3T3-F442A with SM for 2 h or 24 h. Fig. 1A shows
the results of three experiments in which SM was added for
2 h. The ratio of relative £uorescence units of PPARQ to
L-actin expressed as a percentage of control values showed
no di¡erence between cells treated or untreated with SM-
PA. Treatment with SM-SNA or SM-LA caused a 6^8% re-
duction of the ratio PPARQ/L-actin mRNA. However, these
decreases were not signi¢cant.
Table 1
Changes in membrane phospholipid contents of adipocytes following 24 h incubation with SMs
Phospholipid Untreated cells SM
SM-PA SM-SNA SM-LA
SM 4.7 þ 0.2a 5.6 þ 0.2* 5.4 þ 0.3* 6.6 þ 0.5*
PS 6.6 þ 0.2 6.4 þ 0.4 7.5 þ 0.1 5.8 þ 0.3*
PI 12.9 þ 0.3 13.0 þ 0.4 15.1 þ 1.6 11.0 þ 0.5*
PE 32.7 þ 1.9 31.9 þ 1.4 31.0 þ 1.3 30.5 þ 1.6
PC 43.1 þ 1.2 43.2 þ 2.6 41.1 þ 0.9 46.1 þ 1.3
*P6 0.05: SM-treated cells versus untreated cells.
aData are reported as relative percentage of total phospholipids. Values are the mean þ S.E.M. (n = 3). PI, phosphatidylinositol; PS, phosphati-
dylserine; PE, phosphatidylethanolamine; PC, phosphatidylcholine.
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By contrast, adding SM to the culture medium for 24 h
signi¢cantly decreased the PPARQ/L-actin mRNA levels
(Fig. 1B). The reductions were 8% (P6 0.05), 13%
(P6 0.01) and 33% (P6 0.001) for cells treated with SM-
PA, SM-SNA and SM-LA respectively. The decreases in
PPARQ mRNA were not due to some toxic e¡ect of SM.
There was no loss of adhesion of 3T3-F442A adipocytes
under these conditions. Cell viability determined by trypan
blue was greater than 98% in all cases.
3.2. E¡ect of SMs on PPARQ protein synthesis
We used Western blotting to determine whether the fall in
PPARQ mRNA after incubation of adipocytes with SM for
24 h resulted in a fall in PPARQ protein. There was a signi¢-
cant decrease in total PPARQ (PPARQ1 plus PPARQ2) protein
in 3T3-F442A adipocytes incubated for 24 h with SM (Fig.
2A). In rank order the decreases were SP-PA6 SM-
SNA6 SM-LA. As percentages they were 315% (P6 0.05),
318% (P6 0.05) and 322% (P6 0.05), respectively.
Fig. 2. The e¡ect of SMs on PPARQ protein in 3T3-F442A adipo-
cytes. Cells were incubated for 24 h with or without 15 WM SM.
SMs were dissolved in ethanol. Control cells were incubated with
the same ratio of ethanol. PPARQ protein was determined using an
antibody that recognizes the two isoforms of PPARQ (A) or an anti-
body that recognizes the Q2 isoform of PPARQ (B). The e¡ects of
three SMs having di¡erent acyl chains were determined. Each histo-
gram represents the average þ S.E.M. of three experiments.
*P6 0.05, **P6 0.01, ***P6 0.001: SM-treated cells versus cells
without SM.
Fig. 1. The e¡ect of SMs on PPARQ mRNA levels in 3T3-F442A
adipocytes. Cells were incubated for 2 h (A) or 24 h (B) with or
without 15 WM SM. SMs were dissolved in ethanol. Control cells
were incubated with the same volume of ethanol. mRNA PPARQ
was measured by £uorescent RT-PCR. The e¡ects of three SMs
with di¡erent acyl chains were determined. Each histogram repre-
sents the average þ S.E.M. of three experiments. *P6 0.05,
**P6 0.01, ***P6 0.001: SM-treated cells versus cells without SM.
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A similar result was obtained for the PPARQ2 protein (Fig.
2B). SM-PA, SM-SNA and SM-LA signi¢cantly decreased the
concentration of this PPAR subtype compared to controls.
The e¡ect of SM-LA was much more pronounced than that
of SM-PA or of SM-SNA: 329% (P6 0.001), as against
311% (P6 0.01) and 322% (P6 0.01), respectively.
3.3. E¡ect of SMs on phospholipid pro¢le and cholesterol
content of adipocyte membranes
To verify whether the changes in PPARQ mRNA and pro-
tein levels were related to a signi¢cant uptake of SM in cell
membranes, we determined the phospholipid composition and
cholesterol of the total membranes of adipocytes treated with
SM for 24 h. The major phospholipids were 629.5 þ 20.1 Wg/
mg protein in SM-untreated cells. The SM content was
29.4 þ 1.5 Wg/mg protein and represented 4.7 þ 0.2% of the
phospholipids. Cholesterol was 68.4 þ 4.4 Wg/mg protein.
There was a signi¢cant (P6 0.05) increase in SM levels :
19%, 15% and 40% for cells treated with SM-PA, SM-SNA
and SM-LA, respectively (Table 1). No signi¢cant change
occurred in the other phospholipid classes, except for PS
and PI in SM-LA-treated cells (Table 1). Membrane ceramide
and sphingosine contents were very weak and there was no
signi¢cant change in SM-treated cells (data not shown). The
increase in SM content of total membranes was associated
with an increase in cholesterol levels : 19% (81.7 þ 7.0 Wg/mg
protein, not signi¢cant), 21% (83.0 þ 4.4 Wg/mg protein,
P6 0.05) and 20% (82.7 þ 3.8 Wg/mg protein, P6 0.01)
for cells treated with SM-PA, SM-SNA and SM-LA, respec-
tively.
4. Discussion
We have shown that exogenous SMs in the culture medium
of 3T3-F442A adipocytes for 24 h signi¢cantly reduce the
concentrations of PPARQ mRNA and protein. TNF-K has
also been found to reduce the levels of PPARQ mRNA in
3T3-L1 adipocytes [9,22]. Intracellular signaling molecules
such as H2O2, lyso-PC, and phorbol 12-myristate 13-acetate
also decrease the expression of PPARQ in rat mature adipo-
cytes [23]. Phorbol ester stimulates SM synthesis in HL-60 and
NIH 3T3 cells [24,25]. TNF-K, H2O2 and lyso-PC directly or
indirectly a¡ect the SM pathway in a variety of cells by acti-
vating sphingomyelinase [26^30]. The major products of SM
hydrolysis are phosphocholine and ceramide, with the latter
being further converted to sphingosine and fatty acids by
ceramidase. However, no direct link between the SM metab-
olites and PPARQ has been reported. Previous studies carried
out in the absence of an agent activating sphingomyelinase
have shown that loading SM into human ¢broblasts and lym-
phoid cell lines is followed by an intracellular catabolism of
exogenous SM with the formation of ceramide [31]. In our
hands, only very small amounts of ceramide and sphingosine
were detected in 3T3-F442A adipocytes and the uptake of SM
into cells caused no signi¢cant increments in SM metabolites.
Our data indicate that the regulation of PPARQ expression
depends on the length of the acyl chain of SM. The longer the
acyl chain, the greater the fall in PPARQ gene expression and
protein levels. Our results are in agreement with published
data suggesting that fatty acids with 24 carbons inhibit ex-
pression of such PPARs. In fact the activation of PPARK,
determined by the chloramphenicol acetyltransferase activity
in HeLa cells, was below the basal levels found with the very
long chain (24:1) nervonic acid [32]. In the present study, the
membrane SM contents of adipocytes treated with the three
SMs are di¡erent. Although the di¡erences are not signi¢cant,
the higher membrane SM content in SM-LA-treated adipo-
cytes could explain the higher inhibition of PPARQ gene ex-
pression and protein levels. It also seems possible that the
large chain asymmetry of SM-LA could play a role in the
mechanisms whereby SM blocks the synthesis of PPARQ.
It is noteworthy that the increased membrane SM contents
were related with increased cholesterol contents. These data
are in agreement with previous reports showing that loading
cells with SM causes an increased cholesterol synthesis [33,34]
and positive correlations between SM and cholesterol levels in
biological membranes [35]. The increased cholesterol content
could also have an indirect role in PPARQ expression.
SREBP-1 is a member of the family of transcription factors
designated ADD1/SREBP (adipocyte determination di¡eren-
tiation-dependent factors/sterol regulatory element binding
protein), which are proteins bound to the membranes of the
endoplasmic reticulum. Proteolytic cleavage releases active
NH2-terminal fragments from cell membranes [36]. Upon en-
tering the nucleus, these active domains activate the transcrip-
tion of several genes involved in lipid metabolism and PPARQ
[37,38]. Now, cholesterol inhibits the proteolytic cleavage of
ADD1/SREBP1 [36] and an increased cholesterol synthesis in
3T3-F442A could lead to an inhibition of PPARQ expression
and protein levels.
Other mechanisms may be involved. They may include a
reduced transcription and/or an increased turnover of the re-
ceptor mRNA levels. A mechanism involving auto-regulation
of the receptor may also play a part, as suggested in a recent
report on the interaction of troglitazone with 3T3-L1 adipo-
cytes [39]. A regulation pathway involving p38 mitogen-acti-
vated protein kinase is also possible [40]. The transcription of
the PPARQ gene is impaired by p38 inhibitors [41].
In conclusion, these in vitro ¢ndings support our previous
in vivo report that the membrane SM content is inversely
correlated with the levels of PPARQ mRNA in the adipose
tissue of obese women [11]. The fatty acid content of SM,
particularly the very long chain fatty acids, could be impor-
tant. The biosynthesis of these fatty acids can be modi¢ed in
response to a diet [42]. They are also increased in pathological
states. These very long chain fatty acids accumulate in the cell
membranes of alcoholic patients [43]. Lastly, the levels of the
PPAR mRNA are decreased in the livers of ethanol-fed rats
[44]. The role of these very long chain fatty acids in the reg-
ulation of nuclear receptors therefore deserves further inves-
tigation.
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